Literature DB >> 17724792

Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.

H Taniguchi1, H Yamamoto, N Akutsu, K Nosho, Y Adachi, K Imai, Y Shinomura.   

Abstract

Hedgehog-interacting protein (HHIP) was identified as a putative antagonist of the Hh pathway and as a target of Hh signalling. Our aim was to clarify the expression profiles and epigenetic alterations of the HHIP gene in gastrointestinal cancer. The expression and promoter epigenetic status of HHIP in cancer cell lines and freshly resected gastrointestinal cancer tissues were examined using RT-PCR, tissue microarray analysis, methylation-specific PCR, and chromatin immunoprecipitation assay. Cells were treated with the demethylating agent 5-aza-2'-deoxycytidine and/or histone deacetylase inhibitor trichostatin A. WST-8 assays and in vitro invasion assays after treatment with HHIP-specific siRNA were performed. HHIP expression levels were reduced in most of the gastrointestinal cancer cell lines and in a certain subset of cancer tissues, and these were correlated with promoter hypermethylation. A heterochromatic structure characterized by neither acetylated H3 nor acetylated H4, and histone H3 lysine 9 hypermethylation and histone H3 lysine 4 hypomethylation was observed in cancer cells in which the HHIP gene was aberrantly silenced. On the other hand, overexpression of the HHIP gene was also found in some cancer tissues and there were significant correlations between protein expression levels of HHIP and those of Sonic hedgehog (Shh), Indian hedgehog, Patched, and glioma-associated oncogene homologue-1. An association was found between lymph node metastasis and HHIP silencing in colorectal cancer tissues with strong Shh expression and between advanced TNM stage and HHIP silencing in diffuse-type gastric cancer tissues with strong Shh expression. Down-regulation of HHIP expression by siRNA resulted in a significant increase in colon cancer cell growth and invasion in vitro. Silencing of the HHIP gene due to hypermethylation and chromatin remodelling appears to be frequently involved in gastrointestinal tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724792     DOI: 10.1002/path.2216

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  29 in total

1.  Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.

Authors:  Xiaobo Zhou; Rebecca M Baron; Megan Hardin; Michael H Cho; Jan Zielinski; Iwona Hawrylkiewicz; Pawel Sliwinski; Craig P Hersh; John D Mancini; Ke Lu; Derek Thibault; Amy L Donahue; Barbara J Klanderman; Bernard Rosner; Benjamin A Raby; Quan Lu; Adriana M Geldart; Matthew D Layne; Mark A Perrella; Scott T Weiss; Augustine M K Choi; Edwin K Silverman
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

2.  Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus.

Authors:  Ling Yang; Li-Shu Wang; Xiaoxin Luke Chen; Zoran Gatalica; Suimin Qiu; Zhihua Liu; Gary Stoner; Hongwei Zhang; Heidi Weiss; Jingwu Xie
Journal:  Int J Biochem Mol Biol       Date:  2012-02-10

3.  Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.

Authors:  Peichao Li; Xiaoru Zhang; Anthony J Murphy; Max Costa; Xiaogang Zhao; Hong Sun
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

4.  The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.

Authors:  Liang Chang; Ping Zhang; Dan Zhao; Huibin Liu; Qiushi Wang; Chenlong Li; Wenzhong Du; Xing Liu; Haitao Zhang; Zhiren Zhang; Chuanlu Jiang
Journal:  Tumour Biol       Date:  2015-10-19

5.  Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.

Authors:  Maria A Hahn; Torsten Hahn; Dong-Hyun Lee; R Steven Esworthy; Byung-Wook Kim; Arthur D Riggs; Fong-Fong Chu; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer.

Authors:  Elena Flowers; Annesa Flentje; Jon Levine; Adam Olshen; Marilyn Hammer; Steven Paul; Yvette Conley; Christine Miaskowski; Kord M Kober
Journal:  Biol Res Nurs       Date:  2019-01-31       Impact factor: 2.522

7.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

8.  Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.

Authors:  Toshikuni Oka; Hiroyuki Yamamoto; Shigeru Sasaki; Masanori Ii; Keiichi Hizaki; Hiroaki Taniguchi; Yasushi Adachi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

9.  Activation of hedgehog signaling is not a frequent event in ovarian cancers.

Authors:  Ling Yang; Jing He; Shuhong Huang; Xiaoli Zhang; Yuehong Bian; Nonggao He; Hongwei Zhang; Jingwu Xie
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

10.  Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.

Authors:  Nathan J Bowen; L DeEtte Walker; Lilya V Matyunina; Sanjay Logani; Kimberly A Totten; Benedict B Benigno; John F McDonald
Journal:  BMC Med Genomics       Date:  2009-12-29       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.